Cite
The Association Between CYP2C19 Genotype and of In-stent Restenosis Among Patients with Vertebral Artery Stent Treatment.
MLA
Lin, Yong ‐.Juan, et al. “The Association Between CYP2C19 Genotype and of In-Stent Restenosis Among Patients with Vertebral Artery Stent Treatment.” CNS Neuroscience & Therapeutics, vol. 20, no. 2, Feb. 2014, pp. 125–30. EBSCOhost, https://doi.org/10.1111/cns.12173.
APA
Lin, Y. ‐ J., Li, J. ‐ W., Zhang, M. ‐ J., Qian, L., Yang, W. ‐ J., Zhang, C. ‐ L., Shao, Y., Zhang, Y., Huang, Y. ‐ J., & Xu, Y. (2014). The Association Between CYP2C19 Genotype and of In-stent Restenosis Among Patients with Vertebral Artery Stent Treatment. CNS Neuroscience & Therapeutics, 20(2), 125–130. https://doi.org/10.1111/cns.12173
Chicago
Lin, Yong ‐ Juan, Jing ‐ Wei Li, Mei ‐ Juan Zhang, Lai Qian, Wen ‐ Jie Yang, Chun ‐ Lei Zhang, Yuan Shao, Yang Zhang, Yu ‐ Jie Huang, and Yun Xu. 2014. “The Association Between CYP2C19 Genotype and of In-Stent Restenosis Among Patients with Vertebral Artery Stent Treatment.” CNS Neuroscience & Therapeutics 20 (2): 125–30. doi:10.1111/cns.12173.